跳至主要内容
临床试验/JPRN-UMIN000025799
JPRN-UMIN000025799已完成未知

Effects of monthly injected ibandronate on bone mineral density and microstructure in patients with primary osteoporosis after teriparatide treatment. - Effects of injected ibandronate with primary osteoporosis after teriparatide treatment. MONUMENT Study

agasaki University Hospital Department of Orthopaedic Surgery0 个研究点目标入组 66 人开始时间: 2017年1月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
55years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1Patients with a history of critical heart disease, hepatic disease, kidney disease, diabetes mellitus, cancer, endcrine disease, metabolic disease, and secondary osteoporosis. 2Patients taking steroids more than 5mg, and drugs affecting bone metabolism. 3Patients with a history of allergy to ibandronate or bisphosphonate and hypocalcemia. 4Patients with a history of Participation in clinical trials. 5More than 3 vertebral fractures between L1 toL4. 6Patients judged inappropriate by author.

研究者

发起方
agasaki University Hospital Department of Orthopaedic Surgery

相似试验